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Abstract 
Objective: The aim of the current study was to examine whether and to what extent mood 
disorders, comprising major depression and bipolar disorder, are accompanied by structural 
changes in the brain as measured using voxel-based morphometry (VBM). 
Methods: We have performed a VBM study using a 3Т MRI system (GE Discovery 750w) in 
patients with mood disorders (n=50), namely 39 with major depression and 11 with bipolar 
disorder, compared to 42 age, sex and education matched healthy controls.  
Results: Our results show that depression was associated with significant decreases in grey 
matter (GM) volume of the regions located within the medial frontal and anterior cingulate 
cortex on the left side and middle frontal gyrus, medial orbital gyrus, inferior frontal gyrus 
(triangular and orbital parts), and middle temporal gyrus (extending to the superior temporal 
gyrus) on the right side. When the patient group was separated into bipolar disorder and major 
depression the reductions remained significant only for the patients with major depressive 
disorder. 
Conclusions: Using VBM the present study was able to replicate decreases in GM volume 
restricted to frontal and temporal regions in patients with mood disorders mainly major 
depression, as compared with healthy controls.   
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Significant outcomes 
1. Unipolar major depression is characterized by decrease a in anterior cingulate cortex grey 
matter explaining in part aberrations in cognitive and affective regulation, attention, problem 
solving, motivation, and decision making. 
2. Unipolar major depression is characterized by decreases in orbitofrontal cortex grey matter 




1. The bipolar disorder study sample was relatively small. 
2. Recently, major biological differences were detected between BD1 and BD2 patients, and 
therefore, future research should also examine differences among both BD subtypes. 
3. Enhanced neuro-oxidative pathways with neurodegenerative effects are more expressed in 
unipolar depressed that in bipolar patients and therefore future research should examine 




Depression is one of the most common psychiatric disorders with increasing frequency, and 
immense social, and economic burden 1. The clinical representation encompasses affective, 
cognitive and somatic complains such as low mood, anxiety, lack of pleasure and interest, 
disturbances of sleep and appetite, decreased self-esteem, thoughts of guilt, hopelessness, and 
even suicide. Important insight into the underlying pathophysiological mechanisms has been 
gained through recent advances in both structural and functional neuroimaging but many issues 
remain to be resolved 2,3. 
 One major such problem is the question of whether and to what extent depression causes 
structural changes in the brain. The majority of the individual studies and meta-analyses 
published in this field are positive about gray matter (GM) volume reductions in various 
cortical regions in depressed patients (unipolar and bipolar alongside) compared to healthy 
controls 4-7. The most consistent findings appear to be related to GM loss in medial frontal 
cortex (MFC), anterior cingulate cortex (ACC) and orbitofrontal cortex (OFC) with less 
evidence about subcortical structures such as the amygdala and the hippocampus 4,8-11. 
Nevertheless, a number of studies have failed to detect some regional changes in GM volume 
(for instance ACC) while confirming others (OFC) 12,13.  
In addition, the exact localization (bilateral, left or right) and the extent of the GM reductions 
reported often varies from one study to another. For instance, the meta-analysis by Lai 6 
detected GM loss in bilateral ACC while  Arnone et al. 5 demonstrated a decrease only in  right 
ACC in major depression. Bipolar depression, on the other hand, appears to affect the left ACC 
7. Similar controversies exist about the reduction of the GM in OFC spanning from bilateral 
engagement of its medial and lateral parts to only left or right sided loss 4,5,14.  
These and other inconsistencies can be explained by the heterogeneity of the patient samples 
(unipolar vs bipolar depression, severity, psychotic features, remission, medication status), 
variability of the image acquisition parameters, and flexibility of the methods employed (a 
priori defined regions of interest (ROIs) or whole brain analysis such as voxel-based 
morphometry). In an attempt to meet the crucial need for replication studies in the field of 
psychiatric neuroimaging we have performed a voxel-based morphometry study on a sample 
of depressed patients (both unipolar and bipolar) compared to matched group of healthy 
controls.  
We have assumed that in many cases the “unipolar” depression as defined in major depressive 
disorder (MDD) might be interpreted within the context of the bipolar spectrum as well 15-17, 
especially when the hypomanic episodes have manifested on sub-threshold, latent or mixed 
syndrome level 17-20 and therefore might have not been properly registered in medical records. 
Despite recent efforts to understand the underlying pathophysiological mechanisms the 
question of whether and to what extent mood disorders cause structural changes in the brain 
remains unclear.  
Hence, the current study was carried out to examine a voxel-based morphometry (VBM) study 
on a sample of mood disorder patients comprising depression and bipolar disorder compared 
to matched group of healthy controls. Our initial hypothesis based on the findings of previous 
VBM studies was that we would find GM volume decreases in cortical areas related to emotion 
processing and cognitive functioning such as ACC, MFC, and OFC.  Based on this assumption 
we first pooled the two patient groups together and compared them to the control subjects and 
subsequently we performed a separate one-way ANOVA analysis with the tree subsamples 
(unipolar, bipolar and healthy) in order to define the shared and distinct GM volume changes 
in patients suffering from those two major psychiatric disorders.  
Methods 
Subjects  
For the present study we recruited fifty adult subjects (mean age 46.7 ± 13.1, 12 males) 
complying with the DSM-IV-TR criteria for depressive episode (single or recurrent) of major 
depressive disorder (n=39) or bipolar disorder (n=11) and forty-two age and sex matched 
healthy controls (mean age 42.6 ± 13.7 y, 13 males). All participants were assessed by general 
clinical interview and the structured Mini International Neuropsychiatric Interview (M.I.N.I 
6.0) 21.  Montgomery–Åsberg Depression Rating Scale (MADRS) 22 was used for assessment 
of severity.  Subjects were excluded if they had a second axis-I diagnosis (psychotic, anxiety, 
substance related disorder) or severe suicidal risk (10th item of MADRS ≥2).  
Healthy controls did not comply with any of the DSM-IV-ТR diagnoses included in the 
M.I.N.I., and had no history of any psychiatric disorder. Exclusion criteria for both patients 
and healthy controls were the following: major medical illness, neurological disease, history of 
head trauma with loss of consciousness.  All participants provided a written informed consent 
complying with the Declaration of Helsinki and the study was approved by the University’s 
Ethics Committee (P-1369/29.05.2015). 
MRI acquisition and analysis 
High resolution structural scans Sag 3D T1 FSPGR sequences were obtained from all 
participants on a 3Т MRI system (GE Discovery 750w) with the following parameters - 1 mm 
slice thickness, 256 х 256 matrix,  7.2 msec relaxation time (TR), 2.3 msec echo time (TE), 12º 
flip angle. 
MRI data were analysed using the SPM 12 (Statistical Paramertic Mapping, 
http://www.fil.ion.ucl.ac.uk/spm/) software running on MATLAB R2017 for Windows and the 
CAT 12 toolbox implemented in SPM (http://www.neuro.uni-jena.de/software/). The 
preprocessing included the following steps: i) segmentation through the CAT 12 toolbox, 
including normalization to standardized MNI (Montreal Neurological Institute) space, 
followed by ii) spatial smoothing with a 8 mm full-width-at-half-maximum Gaussian kernel. 
Total intracranial volume was calculated as well. For the statistical analysis, two general-linear 
models were defined. First, we compared the grey-matter volume between the two groups 
(Patients and Controls) with a two-sample t-test. Next, an ANOVA model was specified that 
further differentiated between subjects with MDD, subjects with bipolar disorder, and healthy 
control subjects. All statistical models included the total intracranial volume as covariate, and 
all results were explored with an FDR-corrected threshold of p<0.05 (false discovery rate) and 
an extent threshold of at least 36 voxels per cluster (expected voxels per cluster).  
Statistical analysis 
We performed statistical analysis of the demographic and clinical characteristics of the 
participants using SPSS 22.0 for Windows. The level of significance was set to p < 0.05 for all 
tests. Student’s t-test was applied for continuous variables and Chi-square test - for categorical 
ones.  
Results  
Demographic and clinical characteristics 
There were no statistically significant differences in age, sex and education level between the 
patients and the healthy controls. Expectedly, patients had significantly higher MADRS scores. 
Clinical characteristics of the patient sample are given in detail in Table 1. The two patient 




Voxel based morphometry (VBM) 
First, we performed a two-sample t-test on the grey-matter images with the total intracranial 
volume, age and sex as covariates. The contrast between controls and patients yielded 
significant differences in clusters encompassing left medial frontal cortex (MFC) and anterior 
cingulate cortex (ACC) as well as right frontal and temporal regions (p (FDR)<0.05). The 
results are described in detail in Table 3 and an illustration is given in Figure 1. The reverse 
contrast exploration did not produce any surviving significant clusters. 
[Table 3] 
[Figure 1] 
In addition, a one-way ANOVA model differentiated between the two patient groups (unipolar 
and bipolar) and the control subjects with the total intracranial volume, age and sex as 
covariates. Significant difference was found between healthy controls and subjects with major 
depression again in a single cluster (297 voxels, p=0.04) located to the left MFC and left ACC 
while frontal and temporal clusters did not survive FDR correction but demonstrated a trend 
towards significance – see Table 4 for details. The contrast between controls and bipolar 
patients as well as the contrast between the two patients’ groups did not reach statistical 




The results of the present study suggest that patients with mood disorders (unipolar and bipolar 
depression combined) demonstrate significant decreases in grey matter volume restricted to 
regions located in medial frontal and anterior cingulate cortex on the left side and middle frontal 
gyrus, medial orbital gyrus, inferior frontal gyrus (triangular and orbital parts), and middle 
temporal gyrus (extending to the superior temporal gyrus) on the right side. Nevertheless, when 
the patient group was divided into bipolar and unipolar depression the reductions remained 
significant only for the unipolar depression patients. These findings replicate some of the 
previous morphometric individual and meta-analytic studies on depression and their 
significance will be discussed in the following lines.  
The biggest cluster showing reduction of grey matter in the patient group in our study was 
situated in MFC and ACC. Accordingly, in medication naïve MDD patients the GM volume 
of the MFC was found to be significantly reduced 10. Similar findings with regard to ACC, 
were reported by a number of individual studies 23-26 although there were some negative 
findings published as well 12,13. Moreover, a recent meta-analysis on 20 VBM studies 
confirmed the reduction of the GM in bilateral ACC 6. Left and less robust right volumetric 
reductions in patients with mood disorders, predominantly in those with unipolar depression 
have been previously identified by Hajek et al. 27. A much more extensive meta-analysis based 
on 101 publications of structural MRI outlined the right ACC as significantly smaller in 
unipolar depression 5. Interestingly, their meta-regression analysis demonstrated that in the left 
ACC a larger effect size was associated with increasing severity of illness and later age of onset 
which might explain the observed discrepancy in the literature on the laterality of the reduction 
in anterior cingulate GM volume.  
In bipolar depression the most prominent structural abnormality as identified by VBM is 
suggested to be the reduction of the left ACC according to the meta-analytical study of Bora et 
al. which included 660 patients and 770 healthy control subjects 7. We might assume that in 
our study several factors including the heterogeneity of the patient sample (both unipolar and 
bipolar), and the severity of illness (moderate to severe depression) have contributed to the 
finding of significant reduction only in the left cingulate region.   
The role of the anterior cingulate cortex in depression has been implicated not only by structural 
but also by functional studies demonstrating changes in task-related and resting-state activity 
28,29. This brain area is involved in cognitive and affective regulation, attention, problem 
solving, motivation, and decision making, and there is a general agreement on the existence of 
an affective and a cognitive subdivision 30. Both have been considered to be involved in the 
pathophysiology of depression as the disorder manifests with affective and cognitive symptoms 
alongside 31,32.  
The other significant clusters demonstrating reduction in GM volume in our patient group were 
located in the orbitofrontal cortex (OFC). This finding is in accordance with at least two meta-
analyses 4,5 identifying the OFC as significantly reduced in depressed patients. Moreover, 
Arnone et al. found that the effect size of the right OFC was larger with increasing proportion 
of patients medicated with antidepressants and antipsychotics while duration of illness was 
associated with smaller effect size 11. In addition, metabolic and functional studies have 
consistently provided evidence for disturbances in this area as characteristic for several 
psychiatric disorders and depression in particular 33,34.  
As part of the prefrontal cortex, the OFC is involved in the processing of rewards and 
punishments which is essential for the complex emotional and social human behaviour 35. A 
meta-analysis of functional MRI in depression has revealed increased activity of the OFC to 
positive emotional stimuli 36. Moreover, treatment response prediction studies suggest that this 
activity is normalized by antidepressants 37. During reward processing this same area was found 
to be hypoactive in unmedicated currently depressed and in remitted patients as well as in 
young individuals with familial risk for depression 38-40.  
The reduction of the GM volume of a cluster in the superior/middle temporal gyrus in our study 
is in accordance with the recent meta-analysis of Arnone et al. 11 where patients with major 
depression demonstrated significant grey matter loss in the temporal gyri bilaterally. 
Interestingly, significantly decreased GM volume in the right middle temporal gyrus was found 
in patients with suicide history compared to healthy controls 41. Similarly, in bipolar disorder 
big cluster of GM reduction encompassing the insula, middle temporal gyrus, superior temporal 
gyrus, temporopolar area, pars opercularis and pars triangularis, inferior frontal gyrus, and 
claustrum on the right side was identified by a recent meta-analysis 42.  
Dividing the patient group into bipolar and unipolar depression in our study led to negative 
result for the bipolar patients compared to both MDD patients and healthy controls. This is in 
accordance with some earlier individual and meta-analytical studies that failed to find 
significant difference in GM volumes between bipolar patients and healthy subjects 43,44. These 
findings contrast our a priori hypothesis that the GM volumes would be similarly affected in 
both major depressive and bipolar affective disorder. Thus, it might be beneficial to analyse 
these two patient groups separately but also with a sufficient sample size which is a limitation 
in our study since the bipolar group consists of only 11 subjects. Yet the effect of the latent, or 
sub-threshold bipolarity as well as the impact of the bipolar spectrum 15 should be properly 
considered as well. 
There is an increasing number of studies in the available literature that directly compare GM 
volumes in unipolar and bipolar depression, but their results are not consistent. One such VBM 
study by Cai et al. 45 detected a cluster of reduced GM volume in the middle cingulate gyrus of 
bipolar I patients, while Chen et al. 46 reported decreases in the left superior frontal gyrus and 
left ACC in MDD patients. Redlich et al. 47 on the other side found reduced GM volumes in 
the hippocampal formation and the amygdala in BD and in the anterior cingulate gyrus in 
unipolar patients. The fact that we were not able to detect any difference between the two 
patient groups in our study might be due to several reasons including the small samples size, 
the unequal distribution of both diagnoses, the diagnostic heterogeneity (bipolar I and II), the 
medication status (most of the patients were medicated) or the statistical threshold (the first 
cited article used an uncorrected p< 0.001). 
 
Conclusion 
In summary, using VBM the present study was able to replicate decreases in GM volume in 
frontal and temporal regions in patients with major depression and bipolar disorder compared 
to healthy controls.  As shown by the further analysis comparing the two patient groups, the 
abovementioned results were mainly driven by the difference between the patients with major 
depression and the healthy individuals. Future studies should examine VBM in patients with 
major depression and bipolar disorder separately as well as in patients with BD1 and BD2. This 
may improve the characterization of the structural abnormalities in mood disorders and their 
subtypes. Moreover, the bias of the sub-syndromal and latent forms of bipolarity should be 
taken into consideration and further investigations should be performed in order to produce 
accurate biological measures differentiating the two clinical diagnoses. In this respect, it is 
interesting to note that there are highly significant differences in neuro-oxidative pathways 
between unipolar depression and bipolar depression with increased damage to lipids and 
proteins coupled with aldehyde formation in unipolar depression as compared with BD1 and 
BD2 48. The greater neuro-oxidative damage observed in unipolar depression may explain the 
greater neurodegenerative or neuroprogressive aberrations in grey matter volume as detected 
in the present study 48,49.  In order to reveal the specific morphological substrate and the exact 
nature of the GM loss in depression longitudinal studies investigating both genetic and 
environmental factors will be needed.     
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Table 1. Demographic and clinical characteristics of all the participants 








Age (mean ± SD) 42.6 ± 13.7   46.4 ± 13.9 0.145a 
Sex (M/F) 13/29  12/38 0.488b 
Education (secondary/higher) 17/25 25/25 0.230b 
MADRS score (mean ± SD) 0.8 ± 1.5 29.4 ± 6.4 *0.000 a 
SD – Standard Deviation, a Independent samples t-test, b  χ2 - test, MADRS - Montgomery–Åsberg 
Depression Rating Scale, * p<0.05. 
Table 2. Demographic and clinical characteristics of the two patient groups 








Age (mean ± SD) 47.7 ± 13.9   43.6 ± 10.5 0.380a 
Sex (M/F) 10/29  3/8 0.843b 
Education (secondary/higher) 20/19 5/6 0.497b 
MADRS score (mean ± SD) 29.1 ± 6.5 30.4 ± 6.4 0.545a 
Age at onset (years) 37.3 ± 12.6 28.1 ± 8.5 *0.030 a 
Number of previous episodes 3.2 ± 3.3 3.8 ± 4.2 0.695a 
Duration of illness (months) 129.6 ± 106.7 185.5 ± 141.7 0.179a 
SSRIs (N) 17 4  
SNRIs (N) 10 3  
TCAs (N) 3 0  
Lithium (N) 0 2  
Atypical antipsychotics (N) 2 7  
Lamotrigine (N) 1 2  
Benzodiazepines (N)  10 2  
No medication (N) 2 1  
SD – Standard Deviation, a Independent samples t-test, b  χ2 - test, MADRS - Montgomery–Åsberg 
Depression Rating Scale, * p<0.05, N – number of patients, MDD – major depressive disorder, BD – 
bipolar disorder, SSRIs - selective serotonin reuptake inhibitors, SNRIs - serotonin noradrenalin 
inhibitors,  TCAs - tricyclic antidepressants.  
 
 
Table 3. Clusters of grey matter volumes significantly reduced in all patients compared to 
healthy controls  
Anatomical localization Cluster size 
(voxels) 
Peak MNI coordinates p-value 
(FDR-
corrected) 
x y z 
Left medial frontal cortex and 
anterior cingulate 
289 -12 56 -5 0.03 
Right middle temporal gyrus 185 51 -8 -23 0.04 
 
Right medial orbital gyrus 85 38 47 -5 0.05 
 
Table 4. Clusters of grey matter volumes significantly reduced in MDD patients compared to 
healthy controls  
Anatomical localization Cluster size 
(voxels) 
Peak MNI coordinates p-value 
(FDR-
corrected) 
x y z 
Left medial frontal cortex and 
anterior cingulate 
297 -14 55 0 0.04 
Right middle temporal gyrus 147 51 -6 -23 0.06 
 
Right inferior frontal gyrus - pars 
triangularis 




Figure 1. Clusters significantly reduced in all patients compared to controls  
 
  
 
 
